1. A 90-Day Repeated Oral Dose Toxicity Study of Alismatis Rhizoma Aqueous Extract in Rats
- Author
-
Ho-Kyung Jung, Mu-Jin Lee, Seong-Ho Ham, Jong-Choon Kim, Sung-Jin Park, Kiho Lee, Ji-Hun Jang, Je-Won Ko, Jin-Han Shon, Tea-Gyeong Seong, Yong-Min Kim, Byung-Kwan Ahn, Mi-Ok Sim, Ji-Young Yoon, and Hyun-Woo Cho
- Subjects
NOAEL ,Health, Toxicology and Mutagenesis ,medicine.medical_treatment ,ved/biology.organism_classification_rank.species ,010501 environmental sciences ,Hematocrit ,Pharmacology ,Toxicology ,030226 pharmacology & pharmacy ,01 natural sciences ,Alismatis rhizome aqueous extract ,Sub-chronic toxicity ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Oral administration ,medicine ,Alisma orientale ,Diuretic effect ,0105 earth and related environmental sciences ,medicine.diagnostic_test ,ved/biology ,Cholesterol ,business.industry ,Albumin ,Traditional medicine ,chemistry ,Toxicity ,Original Article ,Hemoglobin ,Diuretic ,business - Abstract
Alismatis rhizoma (AR), the dried rhizome of Alisma orientale (Sam.) Juzep, is a well-known, traditional medicine that is used for the various biological activities including as a diuretic, to lower cholesterol and as an anti-inflammatory agent. The present study was carried out to investigate the potential toxicity of the Alismatis rhizoma aqueous extract (ARAE) following 90-day repeated oral administration to Sprague-Dawley rats. ARAE was administered orally to male and female rats for 90 days at 0 (control), 500, 1,000 and 2,000 mg/kg/day (n = 10 for male and female rats for each dose). Additional recovery groups from the control group and high dose group were observed for a 28-day recovery period. Chromatograms of ARAE detected main compounds with four peaks. Treatment-related effects including an increase in the red blood cells, hemoglobin, hematocrit, albumin, total protein, and urine volume were observed in males of the 2,000 mg/kg/day group (p < 0.05). However, the diuretic effect of ARAE was considered, a major cause of hematological and serum biochemical changes. The oral no-observed-adverse-effect level (NOAEL) of the ARAE was > 2,000 mg/kg/day in both genders, and no target organs were identified.
- Published
- 2019
- Full Text
- View/download PDF